News Announcement

Morepen Laboratories: Outcome of Board Meeting

This is to inform you that the Board of Directors of the Company, in their meeting held on Thursday, 1st November, 2018 (Timings: Meeting commenced at 12.00 Noon and concluded at 3.40 p.m.), have inter-alia considered and approved the Standalone & Consolidated Un-Audited Financial Results of the Company for the Quarter and Half year ended 30th September, 2018, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.